Table 3 Study of factors associated with HR-HPV infection
From: Molecular characterization of high-risk human papillomavirus (HR-HPV) in women in Lomé, Togo
HPV+ (n = 128) | HPV- (n = 112) | Total (n = 240) | P-value | |
|---|---|---|---|---|
Age n (%) | 0.42 | |||
≤ 30 | 52(58.4) | 37(41.6) | 89 | |
31–49 | 51(49.0) | 53(51.0) | 104 | |
≥ 50 | 25(53.2) | 22(46.8) | 47 | |
Total | 128(53.3) | 112(46.7) | 240 | |
Age of First Intercourse n(%) | 0.85 | |||
0–18 | 35(50.7) | 34(49.3) | 69 | |
18–24 | 84(54.2.) | 71(45.8) | 155 | |
24–30 | 8(57.1) | 6(42.9) | 14 | |
Total | 127(53.4) | 111(46.6) | 238a | |
Number of sexual partner n(%) | 0.58 | |||
No Partner | 54(56.8) | 41(43.2) | 95 | |
One Partner | 21(50.0) | 21(50.0) | 42 | |
Multiple Partners | 50(50.0) | 50(50.0) | 100 | |
Total | 125(52.7) | 112(47.3) | 237a | |
VIA/VIL n (%) | 0.25 | |||
Negative | 125(52.7) | 112(47.3) | 237 | |
Positive | 3(100.0) | (0.0) | 3 | |
Total | 128(53.3) | 112(46.7) | 240 | |